PI Perspective #27

April 1999     View PDF     En español

Expanded Access

These new drugs are currently available free of charge while awaiting final FDA approval.

Amprenavir (PI) 800-248-9757
For anyone tolerating or failing current protease inhibitor therapy and needing another new drug for treatment strategy.

Adefovir (NtRTI) 800-445-3235
For anyone failing current therapy and requiring an additional new drug for treatment strategy.